South Dakota 2024 Regular Session

South Dakota Senate Bill SB12

Introduced
1/9/24  
Refer
1/9/24  
Report Pass
1/18/24  
Engrossed
1/19/24  
Refer
1/22/24  
Report Pass
2/2/24  
Enrolled
2/5/24  

Caption

Authorize certain employer actions regarding the use of cannabis by an employee or a prospective employee.

Impact

The bill has significant implications for state laws concerning employment and drug testing. By clarifying the rights of employees using medical cannabis while simultaneously providing exemptions for safety-sensitive positions, SB12 attempts to balance the rights of workers with the safety concerns of employers. This could lead to changes in workplace policies and procedures surrounding drug testing and employment discrimination, paving the way for cannabis use in some capacities while retaining strict regulations in safety-critical jobs.

Summary

South Dakota Senate Bill 12 addresses the rights of employees and prospective employees in relation to cannabis use. The bill amends existing statutes to affirm that registered qualifying patients utilizing cannabis for medical purposes should have the same rights as those prescribed pharmaceutical medications when it comes to employer interactions and drug testing. However, the bill also allows employers, particularly in safety-sensitive roles, to take adverse employment actions based on positive cannabis tests, thus maintaining a level of workplace control over the use of cannabis.

Sentiment

Discussions around SB12 have been mixed, reflecting a division in sentiment among lawmakers and stakeholders. Proponents argue that the bill provides necessary protections for individuals who use medical cannabis, fostering a more inclusive workplace environment. Conversely, opponents raise concerns about workplace safety and argue that allowing any level of cannabis use could jeopardize the safety of all employees, especially in industries where safety is paramount.

Contention

Notable points of contention include the bill's provisions regarding safety-sensitive roles and the balance between employee rights and employer responsibilities. Critics express apprehension that the bill may inadvertently encourage a lax approach towards cannabis use in workplaces, which could lead to challenges in ensuring employee and public safety. As cannabis legislation evolves, the establishment of clear guidelines for employers and employees regarding drug testing and safety will be crucial in addressing these concerns effectively.

Companion Bills

No companion bills found.

Previously Filed As

SD SB109

Require employers to disclose compensation or range of compensation to applicants and employees.

SD SB3

Prohibit the issuance of a written certification to a pregnant woman or breastfeeding mother for purposes of medical cannabis use.

SD HB1053

Prohibit the issuance of a written certification to a pregnant woman or breastfeeding mother for purposes of medical cannabis use.

SD HB1102

Clarify and modify requirements related to the medical cannabis program.

SD HB1172

Require a practitioner's medical assessment of a patient to occur in certain facilities for purposes of medical cannabis use.

SD HB1129

Modify and establish provisions related to medical cannabis.

SD SB1

Modify debilitating medical conditions for medical cannabis use.

SD HB1162

Authorize employers to acquire and make available opioid antagonists.

SD SB200

Authorize participation in contracts by certain board members and employees of water districts.

SD HB1150

Provide a medical cannabis patient a registry identification card fee waiver in certain circumstances.

Similar Bills

No similar bills found.